PathologyWatch, a Salt Lake City, UT-based provider of digital dermatopathology services, raised $2M in extension funding.
Backers included Neue Fund, Bioventures GmbH, Lateral Capital, BeniVC, and Sky Ventures.
The company, which has raised over $10M in total capital to date, intends to use the funds for digital dermatopathology development and scale of the laboratory system to extend AI research. The funds will bolster operations to facilitate larger clients and continue progress in developing innovative technology, including the extension of artificial intelligence research for various cancer lines.
Led by Dan Lambert, CEO and co-founder, Pathlogywatch specializes in providing dermatology clinics with fully interfaced EMR reporting and 24/7 access to digital slides. Through these services, dermatology clinics, hospitals and laboratories can improve operational efficiency by speeding up workflow and enhancing patient outcomes by utilizing the expert professional team and partner laboratory services. The digital pathology solution includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR.